N-benzoylpyrazoles are novel small-molecule inhibitors of human neutrophil elastase

Результат исследования: Материалы для журналаСтатья

36 Цитирования (Scopus)


Human neutrophil elastase (NE) plays an important role in the pathogenesis of pulmonary disease. Using high-throughput chemolibrary screening, we identified 10 N-benzoylpyrazole derivatives that were potent NE inhibitors. Nine additional NE inhibitors were identified through further screening of N-benzoylpyrazole analogues. Evaluation of inhibitory activity against a range of proteases showed high specificity for NE, although several derivatives were also potent inhibitors of chymotrypsin. Analysis of reaction kinetics and inhibitor stability revealed that N-benzoylpyrazoles were pseudoirreversible competitive inhibitors of NE. Structure-activity relationship (SAR) analysis demonstrated that modification of N-benzoylpyrazole ring substituents modulated enzyme selectivity and potency. Furthermore, molecular modeling of the binding of selected active and inactive compounds to the NE active site revealed that active compounds fit well into the catalytic site, whereas inactive derivatives contained substituents or conformations that hindered binding or accessibility to the catalytic residues. Thus, N-benzoylpyrazole derivatives represent novel structural templates that can be utilized for further development of efficacious NE inhibitors.

Язык оригиналаАнглийский
Страницы (с... по...)4928-4938
Количество страниц11
ЖурналJournal of Medicinal Chemistry
Номер выпуска20
Статус публикацииОпубликовано - 20 окт 2007
Опубликовано для внешнего пользованияДа


ASJC Scopus subject areas

  • Organic Chemistry